We understand that registering for a conference is not essential right now. Many researchers will be unable to register for a future conference of interest if their organisation is temporarily closed or preventing travel.

Therefore, you can simply register your interest here without committing to attending, and our team will keep you updated regarding deadline reminders and grant opportunities. We hope this service is helpful during this difficult time.

Defects in DNA damage repair and checkpoint control are underlying mechanisms driving tumourigenesis, since they allow for the accumulation of genetic alternations.

In addition, defects associated with these pathways are the underlying cause of several human cancer-prone syndromes.

On the other hand, defects in DNA repair and checkpoint control create vulnerabilities in cancer cells that can be targeted by DNA damaging agents and inhibitors that disrupt checkpoint pathways.

This conference will focus on exploring these vulnerabilities, taking advantage of the synthetic lethality concept and targeting particular DNA repair and checkpoint pathways for cancer therapy.

This conference will bring together basic, translational and clinical investigators to discuss current and future directions, opportunities and obstacles to the development of these anti-cancer modalities and how to best translate these concepts to clinical practice.

This conference explores topics that should appeal to basic, translational, clinical investigators as well as clinicians ranging from academics to industry.